Most Recent
Aristocrat goes head to head with IP Australia over patentability of slot machine
Gaming giant Aristocrat Technologies told a court that if its Lightning Link slot machine was a physical game there would be no doubt about its patentability, as trial kicked off Monday in another case that is pushing back on IP Australia's stance on the patentability of computer-implemented inventions.
Delegate slams door on REA Group’s home loans trade mark
A mortgage broker has successfully opposed REA Group's application to trade mark "realestate.com.au Home Loans", with a delegate finding the mark is not adapted to distinguish REA's online services.
Merck wins docs from Wyeth ahead of hearing on reopening Prevnar 13 trial
Merck Sharp & Dohme has emerged victorious in a battle over documents with Wyeth, as the parties gear up for a hearing on Wyeth's request to reopen a trial over three patents for its Prevnar 13 pneumococcal vaccine.
Pfizer claims Juno infringing patent for post-op painkiller
Two units of US pharmaceutical giant Pfizer have filed a lawsuit seeking damages from Juno Pharmaceuticals for allegedly infringing the patent for post-operative pain drug Dynastat.
Regeneron steps up opposition to Kymab’s human rat patent
US biotechnology company Regeneron Pharmaceuticals has filed a Federal Court challenge after losing its opposition to a patent application by UK biopharmaceutical company Kymab for a method of producing an animal with part-human DNA.
IP Australia stubs out British American opposition to Philip Morris cigarette pack patent
IP Australia has dismissed opposition by British American Tobacco to a patent sought by rival cigarette company Philip Morris that covers a resealable cigarette packet that claims to provide an improved experience for smokers.
Ariosa appeals loss to Sequenom over prenatal genetic test patent
Ariosa Diagnostics has asked the Full Federal Court to hear its challenge to a ruling that its Harmony prenatal test infringed Sequenom's patent for a prenatal genetic test, saying the court's judgment was attended by "sufficient doubt".
Pfizer may seek stay of Merck vaccine patent case
Global pharmaceutical firm Pfizer is mulling an application to stay a lawsuit by Merck Sharp & Dohme seeking to invalidate a patent related to the blockbuster Prevnar 13 vaccine as it awaits the outcome of similar proceedings in the US.
Court to hear a2 Milk trade mark appeals together
The Federal Court will hear two high-stakes trade mark appeals by the a2 Milk Company together, after IP Australia delegates found two marks containing "a2", which is a protein found in cow's milk, were not inherently adapted to distinguish its products.
Patent attorneys sued by firm win bid for Seyfarth docs
Two patent attorneys who are being sued by a boutique IP firm for jumping ship to start their own business have cleared the first hurdle in their fight against preliminary discovery, after a judge found the documents relied upon by their former employer’s lawyers at Seyfarth Shaw were relevant to the case.